CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-03-02 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2011-03-02 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2011-03-02 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2011-03-02 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2011-03-02 | SCHRECK THOMAS A Director | Grant or award | +59,145 | 358,596 | ||
| 2011-03-02 | Hamel Lawrence G Chief Development Officer | Grant or award | +16,899 | 16,899 | ||
| 2011-03-02 | Hamel Lawrence G Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2011-03-02 | Hamel Lawrence G Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2011-03-02 | Rosen Howard B Director | Grant or award | +4,394 | 4,394 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion | +682,904 | 682,904 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion | +328,064 | 1,010,968 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion | +810,129 | 1,821,097 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion | +279,097 | 2,100,194 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion | +14,713 | 2,114,897 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Purchase | +680,000 | $5.00 | $3.4M | 2,794,907 |
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion · Series A Convertible Prefered Stock | −500,000 | 0 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion · Series B Convertible Preferred Stock | −218,750 | 0 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Conversion · Series C Convertible Preferred Stock | −810,129 | 0 | ||
| 2011-02-16 | ACP IV, L.P. 10% owner | Other disposition · Convertible Promissory Notes | −0 | |||
| 2011-02-16 | ACP IV, L.P. 10% owner | Other disposition · Warrant to Purchase Series C Convertible Preferred Stock | −40,865 | 69,588 |
Page 30 of 37 · 732 trades